Treatment cost effectiveness in acute otitis media: A watch-and-wait approach versus amoxicillin

被引：6

作者：

Gaboury, Isabelle ^{[1
,5
]}

Coyle, Kathryn ^{[2
]}

Coyle, Douglas ^{[2
,3
]}

Le Saux, Nicole ^{[4
]}

机构：

[1] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 4Z6, Canada

[2] Univ Ottawa, Dept Community Med & Epidemiol, Ottawa, ON, Canada

[3] Ottawa Hosp, Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada

[4] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada

[5] Eastern Ontario Res Inst, Childrens Hosp, Calgary, AB, Canada

来源：

PAEDIATRICS & CHILD HEALTH | 2010年 / 15卷 / 07期

关键词：

Acute otitis media; Cost effectiveness; Economic analysis; Randomized controlled trial; RESISTANT STREPTOCOCCUS-PNEUMONIAE; CHILDREN; POPULATION; THERAPY; TRIAL; ERA;

D O I：

10.1093/pch/15.7.e14

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

In Canada, antimicrobial treatment is the most common approach for acute otitis media. The aim of the present study was to compare the cost effectiveness of treatment with amoxicillin versus a watch-and-wait approach (WAIT) within a Canadian pediatric setting. Four hundred eighty-eight children, six months to five years of age, who participated in a randomized controlled trial were included in the study. The average medication costs per patient were higher for the amoxicillin group ($17.26) than for the WAIT group ($4.33). However, both health care ($148.44 versus $162.48) and patient costs ($23.50 versus $31.87) were greater for the WAIT group. The mean cost of treatment for the amoxicillin group was $189.20, compared with $198.68 for the WAIT group. Amoxicillin may be cost effective in treating children with acute otitis media. The potential development of antimicrobial resistance was not addressed in the present study.

引用

页码：E14 / E18

页数：5

共 27 条

[1] The real cost of otitis media [J].

Alsarraf, R ;

Gates, GA .

ACTA PAEDIATRICA, 1999, 88 (05) :487-488

[2]

Barkai G, 2005, EMERG INFECT DIS, V11, P829

[3] Acute mastoiditis: Increase in the incidence and complications [J].

Bartolome Benito, M. ;

Perez Gorricho, B. .

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2007, 71 (07) :1007-1011

[4] Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric Medicaid population [J].

Berman, S ;

Byrns, PJ ;

Bondy, J ;

Smith, PJ ;

Lezotte, D .

PEDIATRICS, 1997, 100 (04) :585-592

[5] Bootstrapping: estimating confidence intervals for cost-effectiveness ratios [J].

Campbell, MK ;

Torgerson, DJ .

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1999, 92 (03) :177-182

[6] Costs of otitis media in a managed care population [J].

Capra, AM ;

Lieu, TA ;

Black, SB ;

Shinefield, HR ;

Martin, KE ;

Klein, JO .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (04) :354-355

[7] Comparison of two approaches to observation therapy for acute otitis media in the emergency department [J].

Chao, Jennifer H. ;

Kunkov, Sergey ;

Reyes, Lilia B. ;

Lichten, Stephanie ;

Crain, Ellen F. .

PEDIATRICS, 2008, 121 (05) :E1352-E1356

[8] The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies [J].

Claxton, K .

JOURNAL OF HEALTH ECONOMICS, 1999, 18 (03) :341-364

[9] The problem of protocol driven costs in pharmacoeconomic analysis [J].

Coyle, D ;

Lee, KM .

PHARMACOECONOMICS, 1998, 14 (04) :357-363

[10] The economic cost of otitis media in Canada [J].

Coyte, PC ;

Asche, CV ;

Elden, LM .

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 1999, 49 (01) :27-36

← 1 2 3 →